Antibacterial Agents TRIZ Cases
- Phase Transfer Catalysis for Pleuromutilin Derivative Synthesis
Quaternary ammonium salt catalysts enable high-yield synthesis of pleuromutilin derivatives without chromatography.
- Pyrazolo[3,4-b]pyridine PDE4 Inhibitors for Inflammatory Diseases
Pyrazolo[3,4-b]pyridine compounds inhibit phosphodiesterase type IV to treat inflammatory diseases.
- Ertapenem Sodium Stabilization via Formula II Conversion
Converting ertapenem sodium to Formula II eliminates degradation impurities caused by thermal instability during processing.
- Form L Crystalline PARP Inhibitor Solubility
A specific crystalline form of a PARP inhibitor enhances solubility and stability through controlled slurry formation.
- Bacteroides fragilis probiotic inhibits Enterobacteriae translocation
A non-enterotoxigenic Bacteroides fragilis strain interacts with the intestinal epithelium to inhibit pathogenic bacteria movement.
- Modified Bacteriophage Broad-Spectrum Antibacterial Therapy
Lytic bacteriophage expressing multiple host range determinant proteins replicates within target cells to reduce antibiotic resistance in ESKAPE pathogens.
- 9-Substituted-8-Oxoadenine Compounds for TLR7 Modulation
9-substituted-8-oxoadenine compounds modulate toll-like receptor 7 activity through targeted structural modifications.
- Chitosan Microbeads Magnetic Controlled Drug Release
Chitosan microbeads with magnetic nanoparticles enable non-invasive, controlled therapeutic agent delivery at trauma sites.
- Oligomer-Nitroimidazole Conjugates for Local Gut Retention
Covalent oligomer attachment modifies nitroimidazole drugs to extend intestinal residence time, reducing systemic absorption and extraintestinal side effects.
- Stabilized Vancomycin Lipid Complex for Degradation Control
Liposomal encapsulation protects vancomycin from rapid degradation, maintaining biological activity against resistant bacterial infections.
- Azole Parenteral Formulation via Cosolvency
A cosolvency-based formulation solubilizes azole antifungal agents using alcohol and polyethylene glycol mixtures.
- pH-Responsive Polymer-Drug Conjugates for Antibacterial Efficacy
A polymer-drug conjugate uses masked cationic groups that convert to free cationic forms at acidic pH.
- Gamma-AApeptides Broad-Spectrum Antimicrobial Design
Novel gamma-AApeptides deliver potent antimicrobial action through stable non-natural backbones.
- Valproic Acid Probenecid Combination for Seizure Control
Probenecid inhibits renal tubular secretion of valproic acid to maintain serum levels and prevent seizure loss during beta-lactam antibiotic treatment.
- Antimicrobial Blends for Water-Insoluble Biocide Delivery
A 1,2-diol and phenoxyethanol blend delivers water-insoluble co-biocides in personal care formulations.
- Hybrid Bacteriophage Host Range Determinant Assembly
Combining host range determinant sequences from different bacteriophages expands bacterial infection coverage while simplifying manufacturing complexity.
- Lactoferrin Modified Release Formulation for AIEC Invasion
Modified release bovine lactoferrin prevents bacterial invasion of intestinal cells, avoiding antibiotic side effects in inflammatory bowel disease treatment.